U.S. Markets close in 4 hrs 46 mins

Harte Hanks (HHS) Shares March Higher, Can It Continue?

Zacks Equity Research
UnitedHealth (UNH) agrees with laboratories and diagnostic companies for value based care.

As of late, it has definitely been a great time to be an investor in Harte Hanks, Inc. HHS. The stock has moved higher by 10.4% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider HHS’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as HHS has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand.

Click to see them now>>    


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Harte-Hanks, Inc. (HHS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research